These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15882978)

  • 21. A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1.
    Argasinska J; Zhou K; Donnelly RJ; Hay RT; Lee CG
    J Mol Biol; 2004 Jul; 341(1):15-25. PubMed ID: 15312759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
    Maeda A; Lee BH; Yoshimatsu K; Saijo M; Kurane I; Arikawa J; Morikawa S
    Virology; 2003 Jan; 305(2):288-97. PubMed ID: 12573574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sumoylation of a meiosis-specific RecA homolog, Lim15/Dmc1, via interaction with the small ubiquitin-related modifier (SUMO)-conjugating enzyme Ubc9.
    Koshiyama A; Hamada FN; Namekawa SH; Iwabata K; Sugawara H; Sakamoto A; Ishizaki T; Sakaguchi K
    FEBS J; 2006 Sep; 273(17):4003-12. PubMed ID: 16879611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smt3/SUMO and Ubc9 are required for efficient APC/C-mediated proteolysis in budding yeast.
    Dieckhoff P; Bolte M; Sancak Y; Braus GH; Irniger S
    Mol Microbiol; 2004 Mar; 51(5):1375-87. PubMed ID: 14982631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
    Zhang Z; Liao B; Xu M; Jin Y
    FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of nuclear receptor and coactivator functions by the carboxyl terminus of ubiquitin-conjugating enzyme 9.
    Chang YL; Huang CJ; Chan JY; Liu PY; Chang HP; Huang SM
    Int J Biochem Cell Biol; 2007; 39(5):1035-46. PubMed ID: 17336575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMO-1 modification of the Wilms' tumor suppressor WT1.
    Smolen GA; Vassileva MT; Wells J; Matunis MJ; Haber DA
    Cancer Res; 2004 Nov; 64(21):7846-51. PubMed ID: 15520190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation.
    Tomoiu A; Gravel A; Tanguay RM; Flamand L
    J Virol; 2006 Oct; 80(20):10218-28. PubMed ID: 17005699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SUMO modification through rapamycin-mediated heterodimerization reveals a dual role for Ubc9 in targeting RanGAP1 to nuclear pore complexes.
    Zhu S; Zhang H; Matunis MJ
    Exp Cell Res; 2006 Apr; 312(7):1042-9. PubMed ID: 16469311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
    Kurtzman AL; Schechter N
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5602-7. PubMed ID: 11331779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
    Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
    J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual role for SUMO E2 conjugase Ubc9 in modulating the transforming and growth-promoting properties of the HMGA1b architectural transcription factor.
    Li Y; Lu J; Prochownik EV
    J Biol Chem; 2007 May; 282(18):13363-71. PubMed ID: 17350957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation.
    Yousef AF; Fonseca GJ; Pelka P; Ablack JN; Walsh C; Dick FA; Bazett-Jones DP; Shaw GS; Mymryk JS
    Oncogene; 2010 Aug; 29(33):4693-704. PubMed ID: 20543865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUMO modification of NZFP mediates transcriptional repression through TBP binding.
    Kim M; Chen Z; Shim MS; Lee MS; Kim JE; Kwon YE; Yoo TJ; Kim JY; Bang JY; Carlson BA; Seol JH; Hatfield DL; Lee BJ
    Mol Cells; 2013 Jan; 35(1):70-8. PubMed ID: 23269432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.
    Yunus AA; Lima CD
    Nat Struct Mol Biol; 2006 Jun; 13(6):491-9. PubMed ID: 16732283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage.
    Tan JA; Sun Y; Song J; Chen Y; Krontiris TG; Durrin LK
    J Biol Chem; 2008 Jun; 283(26):18124-34. PubMed ID: 18408014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubc9 interacts with SOX4 and represses its transcriptional activity.
    Pan X; Li H; Zhang P; Jin B; Man J; Tian L; Su G; Zhao J; Li W; Liu H; Gong W; Zhou T; Zhang X
    Biochem Biophys Res Commun; 2006 Jun; 344(3):727-34. PubMed ID: 16631117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.